DrugPatentWatch Database Preview
BAUSCH AND LOMB Company Profile
» See Plans and Pricing
What is the competitive landscape for BAUSCH AND LOMB, and what generic alternatives to BAUSCH AND LOMB drugs are available?
BAUSCH AND LOMB has seventy-seven approved drugs.
There are twenty-two US patents protecting BAUSCH AND LOMB drugs.
There are one hundred and eighty-four patent family members on BAUSCH AND LOMB drugs in forty-two countries and fifty-five supplementary protection certificates in thirteen countries.
Summary for BAUSCH AND LOMB
| International Patents: | 184 |
| US Patents: | 22 |
| Tradenames: | 66 |
| Ingredients: | 53 |
| NDAs: | 77 |
Drugs and US Patents for BAUSCH AND LOMB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | FLUNISOLIDE | flunisolide | SPRAY, METERED;NASAL | 074805-001 | Feb 20, 2002 | AB | RX | No | Yes | Start Trial | Start Trial | ||||
| Bausch And Lomb | DESMOPRESSIN ACETATE | desmopressin acetate | SPRAY, METERED;NASAL | 074830-001 | Jan 25, 1999 | AB | RX | No | Yes | Start Trial | Start Trial | ||||
| Bausch And Lomb | SULTEN-10 | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 087818-001 | Feb 3, 1983 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BAUSCH AND LOMB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch And Lomb | RETISERT | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 021737-001 | Apr 8, 2005 | 6,217,895 | Start Trial |
| Bausch And Lomb | ALREX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020803-001 | Mar 9, 1998 | 4,996,335*PED | Start Trial |
| Bausch And Lomb Inc | LOTEMAX | loteprednol etabonate | GEL;OPHTHALMIC | 202872-001 | Sep 28, 2012 | 5,800,807 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for BAUSCH AND LOMB drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Ophthalmic Solution | 0.5% | ➤ Subscribe | 2012-10-19 |
| ➤ Subscribe | Ophthalmic Solution | 1.5% | ➤ Subscribe | 2013-09-09 |
| ➤ Subscribe | Ophthalmic Solution | 0.07% | ➤ Subscribe | 2013-07-26 |
International Patents for BAUSCH AND LOMB Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Uruguay | 28709 | Start Trial |
| Austria | 528003 | Start Trial |
| Canada | 2551409 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for BAUSCH AND LOMB Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3225249 | 2019C/520 | Belgium | Start Trial | PRODUCT NAME: DESMOPRESSINE OF EEN ACETAATZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: BE497271 - BE497280 20160513 |
| 0694547 | SPC/GB02/027 | United Kingdom | Start Trial | PRODUCT NAME: 2-(2-AMINO-1,6-DIHYDRO-6-OXO-PURIN-9-YL)-METHOXY-3-HYDROXY-1-PROPANYL-L-VALINATE HYDROCHLORIDE (VALGANCICLOVIR HYDROCHLORIDE); REGISTERED: NL RVG 25992 20010920; UK PL 00031/0599 20020425 |
| 0809498 | 10C0038 | France | Start Trial | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
